课题基金 / 基金详情

Development of anti-parkinsonism agent related to endogenous amines as pharmacophore

Development of anti-parkinsonism agent related to endogenous amines as pharmacophore
内源性胺类药效团抗帕金森病药物的研制
批准号:
03557094
负责人:
HIROBE Masaaki
金额:
$6.27万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1993

项目摘要

项目成果

HIROBE Masaaki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It has been known for about 5 years that tetrahydroisoquinoline(TIQ) derivatives may be related to the onset of parkinsonism. TIQ and 1-methyi-1, 2, 3, 4- tetrahydroisoquinoline (1MeTIQ) are endogenous amines coexisting in the brain of many species including humans. Mareover, 1MeTIQ has a preventive effect against parkinsonism in mice.Methyl derivative of TIQs were synthesized in preparative scale. And these pharmacological effects were investigated. From the structure-activity relationship, a methyl group attached 1 position is contributed to locomotive activity. The number of methyl groups is affected toxicity. These findings will be useful for further investigation to find out anti-parkinsonism agents.On the way of the investigation, we found that 1-benzyl-TIQ (1BnTIQ) had very strong neurotoxic character. This compound was also an endogeneous amine in human brain. The content of 1-BnTIQ in parkinsonians is higher than control subjects. So from these data, 1BnTIQ is a very suitable candidate for parkinsonism causing substance.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
M.Tateyama, S.Ohta, T.Nagao, M.Hirobe, H.Ono.: "Effect of 4-phenyl-1, 2, 3, 4-tetrahydroisoquinoline on ambulation induced by injection of methamphetamine into the nucleus accumbens in rats." Neuropharmacology. 32. 243-248 (1993)
M.Tateyama、S.Ohta、T.Nagao、M.Hirobe、H.Ono.:“4-苯基-1,2,3,4-四氢异喹啉对大鼠伏隔核注射甲基苯丙胺诱导的行走的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Tateyama: "4-phenyl tetrahydroisoquinoline,but not nomifensine or cocaine,inhibits methamptetamine-induced dopamine release." Eur.J.Pharmacol.240. 51-56 (1993)
M.Tateyama:“4-苯基四氢异喹啉,但不是诺米芬辛或可卡因,可以抑制甲基苯丙胺诱导的多巴胺释放。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Nakagawa: "A novel metabolite of 3,4-methylenedioxyamphetamine(MDA):formation of 3-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline and its pharmacological" Biol.Pharm.Bull.16. 579-582 (1993)
H.Nakakawa:“3,4-亚甲基二氧基苯丙胺(MDA)的新型代谢物:3-甲基-6,7-亚甲基二氧基-1,2,3,4-四氢异喹啉的形成及其药理学”Biol.Pharm.Bull.16
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Application of Chemical Cytochrome P-450 Model System to Studies on Drug Metabolism.
  • 批准号:
    02453140
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 资助金额:
    $4.93万
  • 财政年份:
    1990
  • 负责人:
    HIROBE Masaaki
  • 依托单位:
Studies on the Development of Novel Anti-inflammatory Based on Superoxide Dismutase Activity
Studies on the Enzyme Reaction Mechanism of Cytochrome P450
Synthesis and Pharmacological Activity of Morphine Epoxide Derivatives.